Itau Unibanco Holding S.A.’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.56M Buy
14,145
+497
+4% +$107K 0.07% 120
2026
Q1
$2.97M Buy
13,648
+715
+6% +$159K 0.07% 96
2025
Q4
$2.96M Buy
12,933
+723
+6% +$165K 0.07% 100
2025
Q3
$2.83M Buy
12,210
+1,379
+13% +$281K 0.09% 84
2025
Q2
$2.01M Buy
10,831
+411
+4% +$76.4K 0.08% 97
2025
Q1
$2.18M Buy
10,420
+1,599
+18% +$311K 0.08% 106
2024
Q4
$1.56M Sell
8,821
-2,671
-23% -$491K 0.05% 101
2024
Q3
$2.27M Buy
11,492
+1,847
+19% +$345K 0.07% 91
2024
Q2
$1.65M Buy
9,645
+416
+5% +$68.9K 0.07% 93
2024
Q1
$1.68M Buy
9,229
+1,485
+19% +$256K 0.07% 65
2023
Q4
$1.2M Buy
7,744
+998
+15% +$145K 0.04% 111
2023
Q3
$1.01M Sell
6,746
-929
-12% -$136K 0.04% 102
2023
Q2
$1.03M Sell
7,675
-1,325
-15% -$194K 0.05% 117
2023
Q1
$1.43M Buy
9,000
+56
+0.6% +$8.56K 0.07% 94
2022
Q4
$1.45M Buy
8,944
+2,450
+38% +$376K 0.06% 102
2022
Q3
$872K Sell
6,494
-1,338
-17% -$192K 0.04% 122
2022
Q2
$1.2M Buy
7,832
+2,718
+53% +$415K 0.04% 132
2022
Q1
$829K Buy
5,114
+4,484
+712% +$651K 0.02% 147
2021
Q4
$86K Buy
630
+91
+17% +$10.7K ﹤0.01% 230
2021
Q3
$58K Buy
539
+192
+55% +$21.9K ﹤0.01% 250
2021
Q2
$39K Buy
+347
New +$39.1K ﹤0.01% 222
2020
Q2
Sell
-1,119
Closed -$85K 124
2020
Q1
$85K Sell
1,119
-911
-45% -$77.6K 0.01% 143
2019
Q4
$180K Buy
+2,030
New +$169K 0.01% 286
2019
Q3
Sell
-3,949
Closed -$287K 300
2019
Q2
$287K Buy
+3,949
New +$310K 0.01% 475
2018
Q4
Sell
-2,103
Closed -$199K 588
2018
Q3
$199K Sell
2,103
-1,754
-45% -$166K 0.01% 267
2018
Q2
$357K Sell
3,857
-1,359
-26% -$133K 0.04% 165
2018
Q1
$494K Sell
5,216
-1,674
-24% -$184K ﹤0.01% 218
2017
Q4
$666K Buy
6,890
+2,117
+44% +$200K 0.04% 136
2017
Q3
$1.34M Buy
4,773
+4,283
+874% +$326K 0.09% 124
2017
Q2
$36K Buy
+490
New +$32.9K ﹤0.01% 327

Other funds holding ABBV

Itau Unibanco Holding S.A.'s ABBV Position: Q2 2026 in Review

Itau Unibanco Holding S.A. increased its AbbVie (ABBV) stake by 3.6% in Q2 2026, buying an estimated $107K and bringing the position to 14,145 shares worth $3.56M. The position accounts for 0.07% of the portfolio, ranked #120.

Itau Unibanco Holding S.A. first reported a position in ABBV in Q2 2017 and has held it in 30 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Itau Unibanco Holding S.A. held 14,145 shares of AbbVie worth $3.56M as of Q2 2026.
  • Itau Unibanco Holding S.A. bought 497 AbbVie shares in Q2 2026, an estimated $107K.
  • AbbVie made up 0.07% of Itau Unibanco Holding S.A.'s portfolio in Q2 2026, its #120 holding.
  • Itau Unibanco Holding S.A. first reported a position in AbbVie in Q2 2017 and has held it in 30 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.